Veracyte, Inc.
VCYT- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001384101
In the last 90 days, Veracyte, Inc. insiders filed 0 open-market purchases and 9 sales; 373 institutions reported holding it in 13F filings for Q2 2026, worth $5.23B in total; ARK Invest is the only superinvestor holding it.
Key figures
- Market capClose on Nov 13, 2026
- $1.96B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $2.86M in total
- 9
- 13F holdersQ2 2026, +39 vs. previous quarter
- 373
- 13F valueReported value at the end of Q2 2026
- $5.23B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $517.1M
- +16.0% year over year
- Net income, FY2025
- $66.4M
- +174.9% year over year
- Free cash flow, FY2025
- $126.6M
- +98.5% year over year
- Revenue, Q3 FY2026
- $151.8M
- +15.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 9.56M
- Shares sold short
- Change
- −262.3K
- −2.7% vs. previous
- Days to cover
- 8.22
- At average daily volume
Superinvestors holding VCYT, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Veracyte, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Veracyte, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2026 (view filing)4:05 PM ET | Sep 24-Oct 27 | 34 daysLate | Holstein JensDirector | SSale | −15.0K | $48.50 | −$727.5K | −35.3%27.5K after | 2 lots10b5-1 |
| Oct 28, 2026 (view filing)4:05 PM ET | Oct 27 | 1 day | Eastham KarinDirector | SSale | −14.8K | $50.00 | −$742.6K | −59.2%10.2K after | 10b5-1 |
| Oct 20, 2026 (view filing)4:10 PM ET | Oct 19 | 1 day | Bhanji MunaDirector | SSale | −1.86K | $43.70 | −$81.5K | −4.4%40.9K after | 10b5-1 |
| Sep 22, 2026 (view filing)5:16 PM ET | Sep 21 | 1 day | Leite JohnGlobal Chief Commercial Off | SSale | −4.01K | $40.00 | −$160.6K | −3.1%124.3K after | 10b5-1 |
| Sep 16, 2026 (view filing)4:08 PM ET | Sep 14 | 2 days | Holstein JensDirector | SSale | −5.00K | $40.95 | −$204.7K | −15.4%27.5K after | 10b5-1 |
| Sep 4, 2026 (view filing)7:54 PM ET | Sep 4 | Same day | Febbo Phillip G.Chief Scientific & Med Officer | SSale | −13.1K | $43.05 | −$564.4K | −9.0%133.0K after | 2 lots10b5-1 |
| Sep 4, 2026 (view filing)7:54 PM ET | Sep 4 | Same day | Chambers RebeccaChief Financial Officer | SSale | −3.65K | $43.10 | −$157.4K | −2.2%166.0K after | 2 lots10b5-1 |
| Sep 4, 2026 (view filing)7:54 PM ET | Sep 4 | Same day | McGuire AnnieEVP, General Counsel | SSale | −3.25K | $43.09 | −$140.2K | −2.4%131.2K after | 2 lots10b5-1 |
| Sep 3, 2026 (view filing)4:48 PM ET | Sep 1 | 2 days | Bhanji MunaDirector | SSale | −1.86K | $42.97 | −$80.1K | −4.2%42.7K after | 10b5-1 |
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Eastham KarinDirector | SSale | −3.73K | $52.89 | −$197.2K | −19.8%15.1K after | 2 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 373 holdersThe largest institutional positions in Veracyte, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,486,437 | $792.1M | 0.01% | +313,819+2.4% | Added |
| FMR LLC | 7,702,746 | $452.4M | 0.02% | −61,103−0.8% | Reduced |
| Artisan Partners Limited Partnership | 5,538,404 | $325.3M | 0.53% | +42,034+0.8% | Added |
| Vanguard Portfolio Management LLC | 4,716,191 | $277.0M | 0.01% | +271,461+6.1% | Added |
| State Street Corp | 4,698,128 | $276.0M | 0.01% | −345,462−6.8% | Reduced |
| Vanguard Capital Management LLC | 3,593,922 | $211.1M | 0.00% | +61,690+1.7% | Added |
| Dimensional Fund Advisors LP | 2,826,524 | $166.0M | 0.03% | −54,566−1.9% | Reduced |
| First Trust Advisors LP | 2,507,902 | $147.3M | 0.09% | +390,856+18.5% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,295,951 | $134.8M | 0.88% | −757,867−24.8% | Reduced |
| Wellington Management Group LLP | 2,274,160 | $133.6M | 0.02% | −284,125−11.1% | Reduced |
Holders of 5% or more of VCYT
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Veracyte, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.20%11.9M shares | +6.80 ppfrom 8.40% | Apr 17, 20252 filings | Aug 1, 2025 | SEC |
| FMR LLC | 13G/A | 7.70%6.17M shares | −2.40 ppfrom 10.10% | May 7, 20257 filings | Nov 5, 2026 | SEC |
| State Street Corp | 13G | 6.30%5.04M shares | +1.00 ppfrom 5.30% | Feb 6, 20234 filings | May 12, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 5.67%4.51M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.20%4.13M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Politician trades
All politician trades in VCYT3 members of Congress reported 15 trades in Veracyte, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Apr 7, 2026 |  Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Mar 9, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Dec 15, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Sell (partial) | $1K-$15K |
| Jul 10, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Nov 11, 2023 |  Josh Gottheimer House · NJ | Buy | $1K-$15K |
House · CA · Apr 7, 2026
Buy$1K-$15K
House · CA · Mar 9, 2026
Buy$1K-$15K
House · CA · Dec 15, 2025
Sell (partial)$1K-$15K
House · CA · Jul 10, 2025
Buy$1K-$15K
House · NJ · Nov 11, 2023
Buy$1K-$15K